Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bregal Sagemount is a leading growth-focused private capital/private equity firm founded in 2012 with headquarters in New York City and offices in Palo Alto and Dallas. It manages over $7.5 billion of committed capital through multiple funds focused on high-growth businesses primarily across North America and Europe. The firm invests flexibly via both debt and equity instruments into market-leading companies spanning software, data services, fintech, digital infrastructure—and notably for this context—healthcare IT & services such as LabVantage’s laboratory information management systems. However, Bregal Sagemount itself does not develop drugs or medical technologies but acts as an institutional financial backer for such businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bregal Sagemount.